Ye, X.Y. et al., Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an Orally Active Novel Selective 11 beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor. J. Med. Chem. (2017)
Release Date
2017-11-01
Peptides
Corticosteroid 11-beta-dehydrogenase isozyme 1: AB